These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8364930)

  • 1. Loss of heterozygosity in familial breast carcinomas.
    Lindblom A; Skoog L; Rotstein S; Werelius B; Larsson C; Nordenskjöld M
    Cancer Res; 1993 Sep; 53(18):4356-61. PubMed ID: 8364930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.
    Cropp CS; Champeme MH; Lidereau R; Callahan R
    Cancer Res; 1993 Dec; 53(23):5617-9. PubMed ID: 8242614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A
    Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S; Jonasdottir O; Eyfjord JE
    Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.
    Futreal PA; Söderkvist P; Marks JR; Iglehart JD; Cochran C; Barrett JC; Wiseman RW
    Cancer Res; 1992 May; 52(9):2624-7. PubMed ID: 1568230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
    Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
    Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
    Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
    Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
    Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
    Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
    Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
    Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
    Cornelis RS; Devilee P; van Vliet M; Kuipers-Dijkshoorn N; Kersenmaeker A; Bardoel A; Khan PM; Cornelisse CJ
    Oncogene; 1993 Mar; 8(3):781-5. PubMed ID: 8437862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
    Tsuda H; Fukutomi T; Hirohashi S
    Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8.
    Kerangueven F; Essioux L; Dib A; Noguchi T; Allione F; Geneix J; Longy M; Lidereau R; Eisinger F; Pébusque MJ
    Oncogene; 1995 Mar; 10(5):1023-6. PubMed ID: 7898921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.
    Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF
    Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
    Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
    Maguire P; Holmberg K; Kost-Alimova M; Imreh S; Skoog L; Lindblom A
    Int J Mol Med; 2005 Jul; 16(1):135-41. PubMed ID: 15942690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.
    Lizard-Nacol S; Lidereau R; Collin F; Arnal M; Hahnel L; Roignot P; Cuisenier J; Guerrin J
    Cancer Res; 1995 Oct; 55(19):4416-9. PubMed ID: 7671254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.